Reducing Medication Errors and Time to Drugs Delivery During Pediatric Cardiopulmonary Resuscitation: a Multicenter RCT
1 other identifier
interventional
130
1 country
6
Brief Summary
The investigators recruit nurses working in 5 swiss Pediatric Emergency Departments or divisions to prepare continuous infusions of vasoactive drugs during a simulation-based pediatric CPR cardiac arrest scenario. According to randomization, nurses will have to prepare and deliver vasoactive drugs following their current conventional methods or by the aim of a mobile tablet application called PedAMINES™. PedAMINES™ is designed to support them step-by-step from order to delivery of these drugs.
- 1.Primary outcome will be to measure in each allocation group the number of medication dosage errors committed during each drug preparation sequence until injection.
- 2.Secondary outcome will be to measure the time to drug preparation (TDP) and time to drug delivery (TDD).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2017
Shorter than P25 for not_applicable
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 12, 2017
CompletedFirst Posted
Study publicly available on registry
January 13, 2017
CompletedStudy Start
First participant enrolled
March 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2017
CompletedJanuary 30, 2018
January 1, 2018
10 months
January 12, 2017
January 29, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Medication dosage errors
To measure in each allocation group the number of medication dosage errors committed during each drug preparation sequence until injection.
On the day of study participation
Secondary Outcomes (1)
Time to drug preparation (TDP) and time to drug delivery (TDD)
On the day of study participation
Study Arms (2)
Arm A (PedAMINES™ / Conventional Method)
EXPERIMENTALA 2-period study where nurses will be randomized to a 15-minute CPR scenario to prepare and deliver Dopamine with the help of PedAMINES™ first, then crossover (incl. washout period) to prepare and deliver Norepinephrine with the help of a Conventional Method.
Arm B (Conventional Method / PedAMINES™)
ACTIVE COMPARATORA 2-period study where nurses will be randomized to a 15-minute CPR scenario to prepare and deliver Dopamine with the help of a Conventional Method first, then crossover (incl. washout period) to prepare and deliver Norepinephrine with the help of PedAMINES™.
Interventions
Each nurse will be asked to prepare a 5 μg/kg/min continuous infusion of dopamine (Period 1) and then to prepare a 0.1 μg/kg/min continuous infusion of norepinephrine (Period 2) for a 25kg boy using the studied delivery devices according to the sequence randomly assigned based on a cross-over design: • PedAMINES™ (Period 1) and then Conventional Method (Period 2)
Each nurse will be asked to prepare a 5 μg/kg/min continuous infusion of dopamine (Period 1) and then to prepare a 0.1 μg/kg/min continuous infusion of norepinephrine (Period 2) for a 25kg boy using the studied delivery devices according to the sequence randomly assigned based on a cross-over design: • Conventional Method (Period 1) and then PedAMINES™ (Period 2)
Eligibility Criteria
You may qualify if:
- To be nurse certified
- To know how to prepare intravenous drugs injection.
- To have previously completed the 5-minute introductory course to the use of PedAMINES dispensed by the investigators of the study.
- Participation agreement
You may not qualify if:
- To have at any time undergone a previous experiment with a cognitive numeric device aimed to help vasoactive drugs preparation.
- To have not undergone the 5-minute introductory course to the use of PedAMINES.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Pediatric Clinical Research Platformlead
- University of Geneva, Switzerlandcollaborator
- University of Lausanne Hospitalscollaborator
- Insel Gruppe AG, University Hospital Berncollaborator
- Neuchâtel Hospital, Neuchâtel, Switzerlandcollaborator
- Fribourg Hospital, Fribourg, Switzerlandcollaborator
- Sion Hospital, Sion, Switzerlandcollaborator
Study Sites (6)
Hôpital de l'Enfance (HEL)
Lausanne, Canton of Vaud, 1000, Switzerland
Hôpital du Valais
Sion, Valais, 1950, Switzerland
Inselspital Bern
Bern, 3010, Switzerland
HFR Fribourg
Fribourg, 1752, Switzerland
Geneva Children's Hospital, Geneva University Hospitals
Geneva, 1205, Switzerland
Hôpital Neuchâtelois
Neuchâtel, 2000, Switzerland
Related Publications (5)
Matos RI, Watson RS, Nadkarni VM, Huang HH, Berg RA, Meaney PA, Carroll CL, Berens RJ, Praestgaard A, Weissfeld L, Spinella PC; American Heart Association's Get With The Guidelines-Resuscitation (Formerly the National Registry of Cardiopulmonary Resuscitation) Investigators. Duration of cardiopulmonary resuscitation and illness category impact survival and neurologic outcomes for in-hospital pediatric cardiac arrests. Circulation. 2013 Jan 29;127(4):442-51. doi: 10.1161/CIRCULATIONAHA.112.125625. Epub 2013 Jan 22.
PMID: 23339874BACKGROUNDSiebert JN, Ehrler F, Combescure C, Lacroix L, Haddad K, Sanchez O, Gervaix A, Lovis C, Manzano S. A Mobile Device App to Reduce Time to Drug Delivery and Medication Errors During Simulated Pediatric Cardiopulmonary Resuscitation: A Randomized Controlled Trial. J Med Internet Res. 2017 Feb 1;19(2):e31. doi: 10.2196/jmir.7005.
PMID: 28148473BACKGROUNDSiebert JN, Gosetto L, Sauvage M, Bloudeau L, Suppan L, Rodieux F, Haddad K, Hugon F, Gervaix A, Lovis C, Combescure C, Manzano S, Ehrler F; PedAMINES Trial Group; PedAMINES Prehospital Group. Usability Testing and Technology Acceptance of an mHealth App at the Point of Care During Simulated Pediatric In- and Out-of-Hospital Cardiopulmonary Resuscitations: Study Nested Within 2 Multicenter Randomized Controlled Trials. JMIR Hum Factors. 2022 Mar 1;9(1):e35399. doi: 10.2196/35399.
PMID: 35230243DERIVEDSiebert JN, Ehrler F, Combescure C, Lovis C, Haddad K, Hugon F, Luterbacher F, Lacroix L, Gervaix A, Manzano S; PedAMINES Trial Group. A mobile device application to reduce medication errors and time to drug delivery during simulated paediatric cardiopulmonary resuscitation: a multicentre, randomised, controlled, crossover trial. Lancet Child Adolesc Health. 2019 May;3(5):303-311. doi: 10.1016/S2352-4642(19)30003-3. Epub 2019 Feb 21.
PMID: 30797722DERIVEDSiebert JN, Ehrler F, Lovis C, Combescure C, Haddad K, Gervaix A, Manzano S. A Mobile Device App to Reduce Medication Errors and Time to Drug Delivery During Pediatric Cardiopulmonary Resuscitation: Study Protocol of a Multicenter Randomized Controlled Crossover Trial. JMIR Res Protoc. 2017 Aug 22;6(8):e167. doi: 10.2196/resprot.7901.
PMID: 28830854DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Johan N Siebert, MD
Geneva Children Hospital, Geneva University Hospitals, Geneva, Switzerland
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Blinding to the purpose of the study during recruitment will be maintained to minimize preparation bias. Nurses will be "unblinded" when the simulated scenario start.
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD: Emergency Physician
Study Record Dates
First Submitted
January 12, 2017
First Posted
January 13, 2017
Study Start
March 1, 2017
Primary Completion
December 31, 2017
Study Completion
December 31, 2017
Last Updated
January 30, 2018
Record last verified: 2018-01
Data Sharing
- IPD Sharing
- Will share
IPD will be deidentified and the study investigators will house the data locally on secure hard disk drives (HDD) at the Geneva Children's Hospital. Data will be freely available to anyone upon request 1 year after study completion. Only deidentified/anonymized data will be shared.